It's a Wrap! Pharma-Biotech Industry Completes 245 North American CAPEX/MRO Projects, $4 Billion in Investments in First-Quarter 2016
It's a Wrap! Pharma-Biotech Industry Completes 245 North American CAPEX/MRO Projects, $4 Billion in Investments in First-Quarter 2016
Attachment: null
SUGAR LAND--April 6, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--A spoonful of sugar and more than $4 billion in investments can help curb the worst of financial fevers. A look back at the first quarter of 2016 reveals the Life Science sector wrapped up construction on a total of 245 North American capital and MRO (maintenance) projects. A recent survey of reported projects in Industrial Info's Pharmaceutical-Biotech Online Database reveals that the projects represent a total investment value (TIV) of $4.2 billion. Within this article: Details of a manufacturing plant in Athens, Georgia owned by Johnson & Johnson (NYSE:JNJ).
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.